tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

BioNxt Enters the Final Stretch Before Human Trials for Next-Generation MS Drug
TipRanks NewswireBioNxt Enters the Final Stretch Before Human Trials for Next-Generation MS Drug
2d ago
BioNxt Launches 15-day Sublingual Cladribine Dosing Optimization Study in Preparation for Human Bioequivalence Study
PremiumTipRanks Newswire
BioNxt Launches 15-day Sublingual Cladribine Dosing Optimization Study in Preparation for Human Bioequivalence Study
3d ago
BioNxt Advances Cladribine Sublingual Film for MS Treatment
PremiumCompany Announcements
BioNxt Advances Cladribine Sublingual Film for MS Treatment
14d ago
BioNxt Solutions Adapts AGM Voting Amid Postal Strike and Launches Marketing Campaign
PremiumCompany Announcements
BioNxt Solutions Adapts AGM Voting Amid Postal Strike and Launches Marketing Campaign
14d ago
BioNxt Advances Semaglutide Oral Film with Successful Trials
PremiumCompany Announcements
BioNxt Advances Semaglutide Oral Film with Successful Trials
14d ago
BioNxt Advances Targeted Chemotherapy Delivery Platform
PremiumCompany AnnouncementsBioNxt Advances Targeted Chemotherapy Delivery Platform
14d ago
BioNxt Solutions Strengthens Market Position with Strategic Advisor and Investor Relations Team
Premium
Company Announcements
BioNxt Solutions Strengthens Market Position with Strategic Advisor and Investor Relations Team
14d ago
BioNxt Solutions Completes Debt Settlement to Strengthen Financial Position
Premium
Company Announcements
BioNxt Solutions Completes Debt Settlement to Strengthen Financial Position
14d ago
BioNxt Secures Fast-Track Patent Filing for MS Treatment
PremiumCompany Announcements
BioNxt Secures Fast-Track Patent Filing for MS Treatment
14d ago
BioNxt Solutions Settles Debt with Share Issuance and Cash Payment
PremiumCompany Announcements
BioNxt Solutions Settles Debt with Share Issuance and Cash Payment
1M ago
BioNxt Solutions Enhances Market Presence with OTCQB Up-Listing
PremiumCompany Announcements
BioNxt Solutions Enhances Market Presence with OTCQB Up-Listing
2M ago
BioNxt Solutions Accelerates U.S. Patent for MS Drug and Secures Broad Platform IP
PremiumCompany Announcements
BioNxt Solutions Accelerates U.S. Patent for MS Drug and Secures Broad Platform IP
2M ago
BioNxt Solutions Boosts Investor Relations with Strategic Engagements in Germany
PremiumCompany AnnouncementsBioNxt Solutions Boosts Investor Relations with Strategic Engagements in Germany
2M ago
BioNxt Solutions Completes Oversubscribed Convertible Debenture Offering
Premium
Company Announcements
BioNxt Solutions Completes Oversubscribed Convertible Debenture Offering
3M ago
BioNxt Solutions Secures Pending Patent Grants for MS Treatment in Europe and Eurasia
Premium
Company Announcements
BioNxt Solutions Secures Pending Patent Grants for MS Treatment in Europe and Eurasia
3M ago
BioNxt Solutions Closes First Tranche of Convertible Debenture Private Placement
PremiumCompany Announcements
BioNxt Solutions Closes First Tranche of Convertible Debenture Private Placement
3M ago
BioNxt Achieves Key Milestone with Cladribine Thin-Film Prototype for MS Treatment
PremiumCompany Announcements
BioNxt Achieves Key Milestone with Cladribine Thin-Film Prototype for MS Treatment
3M ago
BioNxt Solutions Launches $1.2M Convertible Debenture Offering
PremiumCompany Announcements
BioNxt Solutions Launches $1.2M Convertible Debenture Offering
3M ago
BioNxt Solutions Resumes Trading as Cease Trade Order Revoked
PremiumCompany Announcements
BioNxt Solutions Resumes Trading as Cease Trade Order Revoked
4M ago
BioNxt Solutions Launches Feasibility Study for Semaglutide Oral Thin Film
PremiumCompany AnnouncementsBioNxt Solutions Launches Feasibility Study for Semaglutide Oral Thin Film
4M ago
BioNxt Solutions Addresses MCTO Status Amid Filing Delays
Premium
Company Announcements
BioNxt Solutions Addresses MCTO Status Amid Filing Delays
4M ago
BioNxt Solutions Receives Management Cease Trade Order Amidst Filing Delays
Premium
Company Announcements
BioNxt Solutions Receives Management Cease Trade Order Amidst Filing Delays
5M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >